{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:25:50Z","timestamp":1790835950919,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Psychiatric comorbidity has been detected in one-third of bipolar patients. The illness itself may be a precipitating factor for developing substance use and anxiety disorders. Comorbid anxiety disorders with bipolar disorder (BD) are associated with decreased chances of recovery, poorer role functioning, and quality of life, and greater likelihood of suicide attempts. Hence, identifying comorbid symptoms in remitting patients has important preventive and therapeutic implications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>The aim of the study was to estimate the frequency of psychiatric comorbid symptoms in patients of bipolar affective disorder in remission and to identify its relationship with sociodemographic variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology:<\/jats:title>\n                    <jats:p>\n                      This is a cross-sectional study conducted in Father Muller Medical College and Hospital, Mangalore (April 2019\u2013July 2019), which included 90 patients aged 18\u201350 years with BD, manic, or depressive episodes in remission for 8 weeks who were evaluated using mini international neuropsychiatric interview plus, Hamilton rating scale for depression, and young mania rating scale. Sociodemographic details were assessed by a semi-structured pro forma. The data were analyzed using frequency, Chi-square test, and\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Most common psychiatry comorbid symptoms seen in BD were found to be drug dependence\/abuse (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 31), second most common being alcohol dependence\/abuse (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 21), followed by suicidality (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 8), antisocial personality, social phobia, panic disorder, and agoraphobia. Significance was found for suicidality, agoraphobia, and social phobia if the last episode was depressive and for suicidality if index episode was depressive and if age of onset was &gt;40 years.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Psychiatric comorbidities in BD may worsen the course and prognosis of the disorder and hence, clinicians must maintain a high index of suspicion for them. Furthermore, comorbidities may need to be identified and appropriate interventions employed to prevent iatrogenic complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ipj.ipj_233_20","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T11:53:08Z","timestamp":1640001188000},"page":"126-134","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Frequency of psychiatric comorbid symptoms in bipolar disorder patients in remission"],"prefix":"10.4103","volume":"31","author":[{"given":"Aarshie","family":"Koul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Siddharth","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20240829","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2147\/CLEP.S45305","article-title":"Concepts of comorbidities, multiple morbidities, complications, and their clinical epidemiologic analogs","volume":"5","author":"Ording","year":"2013","journal-title":"Clin Epidemiol"},{"key":"R3-19-20240829","first-page":"7","article-title":"Defining the clinical course of bipolar disorder: Response, remission, relapse, recurrence, and roughening","volume":"40","author":"Hirschfeld","year":"2007","journal-title":"Psychopharmacol Bull"},{"key":"R4-19-20240829","first-page":"12","article-title":"Criteria for defining symptomatic and sustained remission in bipolar I disorder: A post-hoc analysis of a 26-week aripiprazole study (study CN138-010)","volume":"41","author":"Masand","year":"2008","journal-title":"Psychopharmacol Bull"},{"key":"R5-19-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.psy.0000151489.36347.18","article-title":"Psychiatric and medical comorbidities of bipolar disorder","volume":"67","author":"Krishnan","year":"2005","journal-title":"Psychosom Med"},{"key":"R6-19-20240829","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1034\/j.1399-5618.2001.30504.x","article-title":"Clinical correlates of psychiatric comorbidity in bipolar I patients","volume":"3","author":"Vieta","year":"2001","journal-title":"Bipolar Disord"},{"key":"R7-19-20240829","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1176\/appi.ajp.161.12.2222","article-title":"Anxiety disorder comorbidity in bipolar disorder patients: Data from the first 500 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD)","volume":"161","author":"Simon","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R8-19-20240829","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5455\/apd.155784","article-title":"Prevalence, psychiatric comorbidity, and quality of life in patients with bipolar disorder in Sivas province","volume":"16","author":"Ozdemir","year":"2015","journal-title":"Anat J Psychiatry"},{"key":"R9-19-20240829","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4103\/0253-7176.135377","article-title":"Co-morbidity in bipolar disorder: A retrospective study","volume":"36","author":"Munoli","year":"2014","journal-title":"Indian J Psychol Med"},{"key":"R10-19-20240829","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jad.2004.12.006","article-title":"Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span","volume":"86","author":"Fenn","year":"2005","journal-title":"J Affect Disord"},{"key":"R11-19-20240829","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton","year":"1967","journal-title":"Br J Soc Clin Psychol"},{"key":"R12-19-20240829","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archpsyc.1988.01800320058007","article-title":"A structured interview guide for the Hamilton depression rating scale","volume":"45","author":"Williams","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"R13-19-20240829","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R14-19-20240829","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: Reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"R15-19-20240829","first-page":"22","article-title":"The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R16-19-20240829","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4088\/JCP.v59n0204","article-title":"Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders","volume":"59","author":"Cassano","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R17-19-20240829","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/S1461145703003432","article-title":"Bipolar comorbidity: From diagnostic dilemmas to therapeutic challenge","volume":"6","author":"Sasson","year":"2003","journal-title":"Int J Neuropsychopharmacol"},{"key":"R18-19-20240829","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1176\/appi.ajp.158.3.420","article-title":"Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder","volume":"158","author":"McElroy","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R19-19-20240829","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/bdi.18_12743","article-title":"Prevalence, pattern, impact, diagnosis and treatment of psychiatric comorbidity in bipolar disorder","volume":"21","author":"Gao","year":"2019","journal-title":"Bipolar Disord"},{"key":"R20-19-20240829","first-page":"35","article-title":"Diagnosing and treating comorbid (complicated) bipolar disorder","volume":"65","author":"McElroy","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R21-19-20240829","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2194-7511-1-15","article-title":"Bipolar disorder with comorbid anxiety disorders: Impact of comorbidity on treatment outcome in cognitive-behavioral therapy and psychoeducation","volume":"1","author":"Hawke","year":"2013","journal-title":"Int J Bipolar Disord"},{"key":"R22-19-20240829","first-page":"8","article-title":"Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders","volume":"67","author":"Keck","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R23-19-20240829","first-page":"108","article-title":"Suicide in bipolar disorder: A review","volume":"26","author":"Latalova","year":"2014","journal-title":"Psychiatr Danub"},{"key":"R24-19-20240829","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/ipj.ipj_15_16","article-title":"Bipolar affective disorder and its impact on various aspects of marital relationship","volume":"26","author":"Grover","year":"2017","journal-title":"Ind Psychiatry J"}],"container-title":["Industrial Psychiatry Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ipj.ipj_233_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:15:16Z","timestamp":1787771716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ipj.ipj_233_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ipj.ipj_233_20","relation":{},"ISSN":["0972-6748"],"issn-type":[{"value":"0972-6748","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}